Literature DB >> 17206398

Rheumatoid arthritis is linked to Proteus--the evidence.

Taha Rashid1, Alan Ebringer.   

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory arthritic and potentially disabling condition, mainly affecting women of middle age and having characteristic clinical features. Various microbial agents were implicated in the causation of RA. Extensive literature based on the results of various genetic, microbiological, molecular, and immunological studies carried out by independent research groups supports the role of Proteus mirabilis bacteria in the etiopathogenesis of RA. New diagnostic markers and criteria and the use of a novel therapeutic protocol in the form of antibiotic and dietary measures are suggested to be used together with current treatments in the management of RA. Prospective longitudinal studies with the use of antimicrobial measures in patients with RA are required to establish the therapeutic benefit of this microbe-disease association.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17206398     DOI: 10.1007/s10067-006-0491-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  71 in total

Review 1.  Genetics of rheumatoid arthritis.

Authors:  Carl Turesson; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2006-01       Impact factor: 7.616

2.  Proteus IgG antibodies and C-reactive protein in English, Norwegian and Spanish patients with rheumatoid arthritis.

Authors:  T Rashid; G Darlington; J Kjeldsen-Kragh; O Forre; A Collado; A Ebringer
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

3.  Lack of reactivity of rheumatoid arthritis synovial membrane DNA with cloned Epstein Barr virus DNA probes.

Authors:  R I Fox; T Chilton; G Rhodes; J H Vaughan
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

4.  Antibodies to four gram-negative bacteria in rheumatoid arthritis which share sequences with the rheumatoid arthritis susceptibility motif.

Authors:  H Tiwana; C Wilson; P Cunningham; A Binder; A Ebringer
Journal:  Br J Rheumatol       Date:  1996-06

5.  Elevation in anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England.

Authors:  H Subair; H Tiwana; M Fielder; A Binder; K Cunningham; A Ebringer; C Wilson; M J Hudson
Journal:  J Rheumatol       Date:  1995-10       Impact factor: 4.666

6.  Elevated levels of anti-proteus antibodies in patients with active rheumatoid arthritis.

Authors:  A Wanchu; S D Deodhar; M Sharma; V Gupta; P Bambery; A Sud
Journal:  Indian J Med Res       Date:  1997-01       Impact factor: 2.375

Review 7.  Considerations with the use of biological therapy in the treatment of rheumatoid arthritis.

Authors:  Roy M Fleischmann; Imran Iqbal; Richard L Stern
Journal:  Expert Opin Drug Saf       Date:  2004-09       Impact factor: 4.250

8.  The potential use of antibacterial peptide antibody indices in the diagnosis of rheumatoid arthritis and ankylosing spondylitis.

Authors:  Taha Rashid; Alan Ebringer; Clyde Wilson; Sukvinder Bansal; Leena Paimela; Allan Binder
Journal:  J Clin Rheumatol       Date:  2006-02       Impact factor: 3.517

9.  Does parvovirus B19 have a role in rheumatoid arthritis?

Authors:  S Nikkari; R Luukkainen; T Möttönen; O Meurman; P Hannonen; M Skurnik; P Toivanen
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

10.  Sequence similarity between HLA-DR1 and DR4 subtypes associated with rheumatoid arthritis and proteus/serratia membrane haemolysins.

Authors:  A Ebringer; P Cunningham; K Ahmadi; J Wrigglesworth; R Hosseini; C Wilson
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

View more
  24 in total

Review 1.  The microbiome in autoimmune diseases.

Authors:  F De Luca; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2019-01       Impact factor: 4.330

2.  Functional identification of the Proteus mirabilis core lipopolysaccharide biosynthesis genes.

Authors:  Eleonora Aquilini; Joana Azevedo; Natalia Jimenez; Lamiaa Bouamama; Juan M Tomás; Miguel Regué
Journal:  J Bacteriol       Date:  2010-07-09       Impact factor: 3.490

Review 3.  Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases.

Authors:  Jing Li; Xiaohui Wang; Fengchun Zhang; Hang Yin
Journal:  Pharmacol Ther       Date:  2013-03-24       Impact factor: 12.310

4.  Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis.

Authors:  D M B T Disaanayake; Joan Faoagali; Hans Laroo; Gerald Hancock; Michael Whitehouse
Journal:  Inflammopharmacology       Date:  2014-01-05       Impact factor: 4.473

Review 5.  Can rheumatoid arthritis be prevented?

Authors:  Kevin D Deane
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-10-02       Impact factor: 4.098

6.  The lung may play a role in the pathogenesis of rheumatoid arthritis.

Authors:  M Kristen Demoruelle; Joshua J Solomon; Aryeh Fischer; Kevin D Deane
Journal:  Int J Clin Rheumtol       Date:  2014

7.  Three enzymatic steps required for the galactosamine incorporation into core lipopolysaccharide.

Authors:  Eleonora Aquilini; Joana Azevedo; Susana Merino; Natalia Jimenez; Juan M Tomás; Miguel Regué
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

8.  Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility.

Authors:  Melanie M Pearson; Mohammed Sebaihia; Carol Churcher; Michael A Quail; Aswin S Seshasayee; Nicholas M Luscombe; Zahra Abdellah; Claire Arrosmith; Becky Atkin; Tracey Chillingworth; Heidi Hauser; Kay Jagels; Sharon Moule; Karen Mungall; Halina Norbertczak; Ester Rabbinowitsch; Danielle Walker; Sally Whithead; Nicholas R Thomson; Philip N Rather; Julian Parkhill; Harry L T Mobley
Journal:  J Bacteriol       Date:  2008-03-28       Impact factor: 3.490

Review 9.  Proteus mirabilis and Urinary Tract Infections.

Authors:  Jessica N Schaffer; Melanie M Pearson
Journal:  Microbiol Spectr       Date:  2015-10

10.  ECA-immunogenicity of Proteus mirabilis strains.

Authors:  Katarzyna Anna Duda; Katarzyna Teresa Duda; Agnieszka Beczała; Katarzyna Kasperkiewicz; Joanna Radziejewska-Lebrecht; Mikael Skurnik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-03-31       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.